GlycoMimetics, Inc.
GLYC
$0.2417
-$0.033-12.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 10.00K | 10.00K | 10.00K | 10.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 10.00K | 10.00K | 10.00K | 10.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 10.00K | 10.00K | 10.00K | 10.00K |
| SG&A Expenses | 18.25M | 17.48M | 18.00M | 18.78M | 19.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.51M | 36.79M | 40.89M | 39.46M | 39.29M |
| Operating Income | -32.51M | -36.78M | -40.88M | -39.45M | -39.28M |
| Income Before Tax | -37.88M | -39.74M | -39.11M | -37.28M | -36.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -37.88 | -39.74 | -39.11 | -37.28 | -36.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.88M | -39.74M | -39.11M | -37.28M | -36.90M |
| EBIT | -32.51M | -36.78M | -40.88M | -39.45M | -39.28M |
| EBITDA | -32.47M | -36.73M | -40.78M | -39.33M | -39.12M |
| EPS Basic | -0.59 | -0.62 | -0.61 | -0.58 | -0.58 |
| Normalized Basic EPS | -0.31 | -0.34 | -0.38 | -0.36 | -0.37 |
| EPS Diluted | -0.59 | -0.62 | -0.61 | -0.58 | -0.58 |
| Normalized Diluted EPS | -0.31 | -0.34 | -0.38 | -0.36 | -0.37 |
| Average Basic Shares Outstanding | 257.91M | 257.82M | 257.68M | 257.48M | 253.37M |
| Average Diluted Shares Outstanding | 257.91M | 257.82M | 257.68M | 257.48M | 253.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |